Treating HER2-mutant advanced biliary tract cancer with neratinib Published 2019-07-15 Download video MP4 360p Recommendations 03:38 Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for ... 04:35 TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia 06:04 Immunotherapy significantly increases the number of patients free from bowel cancer 49:17 Alex Tothill-Brown Was Given a Low Chance of Being Cured 10 Years Ago - It Takes Balls 16:03 Long COVID: New research, common symptoms, long-term effects and treatments with Akiko Iwasaki, PhD 1:02:34 Cavernous Malformation [2020] - Ginger Burden | EP 97 06:26 Encouraging results using mismatched unrelated donors in stem cell transplantation 02:57 Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-... 05:24 Lower levels of inflammatory markers and tumour burden is linked to improvements in PFS with Ide... 04:35 Adjuvant avelumab versus control does not significantly improve DFS but does improve OS in high-... 04:59 Ponatinib is better than imatinib for frontline treatment of newly diagnosed Ph+ acute lymphobla... 02:32 Enfortumab vedotin improves efficacy outcomes in locally advanced or metastatic urothelial cance... 05:00 Transoral surgery and neck dissection with deintensified risk-based post-operative management re... 04:10 Ibrutinib and venetoclax continue to provide benefits for patients with chronic CLL and SLL 49:06 Bipolarcast Episode 1: Interview with Matt Baszucki on Ketogenic Diet and Bipolar Disorder 02:38 ATRA-ATO regimen with idarubicin could become the new standard of care in high-risk acute promye... 59:58 Recovery from AVM (Arteriovenous Malformation) Stroke | Jason Gaudette EP 56 24:35 Carnivore Diet Costco Hack: Watch Me Transform A Chuck Roll Into Mouthwatering Steaks! 59:41 Psychosis, Addiction, Institutions, Jails, Recovery, and Wellbeing 1:02:48 The Final Episode of CHEF AJ LIVE! Q & A with NYT Bestselling Author Dr. Joel Fuhrman - Episode 2078 Similar videos 01:20 Final results from the phase 2 SUMMIT basket trial: targeting HER2+ advanced BTCs with neratinib 02:14 Neratinib in HER2 or HER3 mutant solid tumours 53:34 Translational Dysequilibrium at the Bedside-Bench Interface 08:29 Applied precision cancer medicine in advanced biliary tract cancer 01:57 Dr. Dietrich on Adverse Event Management for Neratinib in Breast Cancer 06:44 Reducing Your Risk With NERLYNX 59:44 Webinar: HER2-targeted therapies in CCA 01:39 Dr. Anders Discusses the Use of Neratinib/Capecitabine for HER2-Positive Brain Metastases 16:38 The HER-2 Pathway in GI Cancer 08:12 Joan Lunden's Breast Cancer Fight 55:02 AC20 - How can we Translate Novel Targets into the Clinic? 00:56 Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting 49:30 CME Livestream with Drs. Michael Pishvaian, Aatur Singhi, Minetta Liu, & Emanuel Petricoin 20:43 Updates in Advanced & Recurrent Endometrial Cancer: Molecular Classification & Emerging Therapies 1:02:02 Improving Outcomes in Molecularly Altered NSCLC Through Precision Testing and Treatment 02:56 Creating a "Living Drug" to Fight Cancer 21:23 HER-2/BRAF/KRAS and MET 18:23 2021 West Oncology | Lung Cancer | Targeted Therapies More results